A 30-year-old New England woman’s symptoms started with a burning sensation in her feet. Over the following two days, the ...

Eupraxia Pharmaceuticals (EPRX) announced additional positive clinical data from its ongoing RESOLVE Phase 1b/2a trial evaluating EP-104GI for ...

Histological scores and symptom scores continue to improve as EP-104GI dose, and area of esophageal coverage, increase Cohort ...

Eosinophilic meningitis, caused by the rat lungworm parasite, can trigger neurological symptoms like burning sensations, ...

Acute respiratory infections (ARIs) are a common cause of illness in children younger than 16 years and adults older than 65 ...

A woman developed an array of symptoms shortly after returning from a vacation, and parasites turned out to be the culprit.

A better understanding of inflammation and lung immunity over the past two decades has led to new, innovative treatments for ...

Researchers are tackling neutrophilic asthma, successfully developing one of the first mouse models of the condition.

A better understanding of inflammation and lung immunity over the past two decades has led to new, innovative treatments for ...

A better understanding of inflammation and lung immunity over the past two decades has led to new, innovative treatments for asthma, including ...

Anti-CD20 mAbs were originally created to treat B cell proliferative diseases such as non-Hodgkin's lymphoma and chronic ...

If approved, Dupixent would be the first and only targeted medicine to treat BP in the U.S.; FDA decision expected by June 20, 2025 </stron ...